This case apparently confirms that sunitinib-related and denosumab-related ONJ might have less pronounced CT alterations in comparison with those usually observed in BRONJ cases. However a possible aid to diagnosis from nuclear medicine techniques is deducible in this case, as well as recently described in BRONJ literature, reporting that bone scan might be more sensible (even if not specific) in identifying ONJ areas.
ONJ UPDATE 2018 CONGRESS ABSTRACTS Osteonecrosi delle ossa mascellari (ONJ) da bifosfonati e altri farmaci: prevenzione, diagnosi, farmacovigilanza, trattamento. Alessandria, 5 maggio 2018
M. Migliario
Primo
;C. Mortellaro;
2018-01-01
Abstract
This case apparently confirms that sunitinib-related and denosumab-related ONJ might have less pronounced CT alterations in comparison with those usually observed in BRONJ cases. However a possible aid to diagnosis from nuclear medicine techniques is deducible in this case, as well as recently described in BRONJ literature, reporting that bone scan might be more sensible (even if not specific) in identifying ONJ areas.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
